Techno Trends

This section presents the latest developments, inventions, and revolutionary technologies that change the face of healthcare.

RevBio Receives Groundbreaking FDA Approval to Trial “Bone Glue” for Fracture Treatment

RevBio has received approval from the U.S. Food and Drug Administration to begin a pilot clinical study of TETRANITE, a regenerative bone adhesive intended to support the repair of complex wrist fractures. ...

SpectraWAVE Receives FDA Clearance for Innovative X1™-FFR, an AI-Enabled, Wire-Free Physiology Solution

SpectraWAVE, Inc., has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its X1™-FFR product. ...

BD Launches BD Incada™ First-of-its-Kind AI-Enabled Healthcare Connectivity Platform

Becton, Dickinson and Company (BD) has introduced the BD Incada™ Connected Care Platform, an AI-enabled, cloud-based system that unifies data from BD devices into a single intelligent ecosystem. ...

Hyperion Surgical Achieves Key Clinical Milestone with Ivy™ Robotic Platform

Hyperion Surgical, Inc. has completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy™ robotic vascular access platform. ...

Bunkerhill Health Secures First-of-its-Kind FDA Approval to Detect Mitral Valve Calcification

Bunkerhill Health has received approval from the U.S. Food and Drug Administration (FDA) for Bunkerhill MAC, an artificial intelligence (AI) tool designed to detect and measure mitral annular calcification (MAC)....

FDA Grants Breakthrough Device Status to CAPS Medical’s PlasmaSure™

CAPS Medical, a clinical-stage MedTech company, has received Breakthrough Device Designation from the U.S. FDA for its PlasmaSure™ System, aimed at treating low- to intermediate-risk non-muscle...

Biolinq Shine™ Receives FDA De Novo Classification for Needle-Free Glucose Sensor

Biolinq Incorporated has received De Novo Classification from the US Food and Drug Administration (FDA) for its lead product, Biolinq Shine™, marking a major regulatory milestone for the company....

Plexāā Launches BLOOM43 Platform for Breast Surgery Prehab in U.S.

Plexāā, a medical technology company focused on improving surgical outcomes, has announced the U.S. launch of its BLOOM43 platform, coinciding with Breast Cancer Awareness Month. The platform combines a wearable preconditioning device and a companion app to help patients prepare for breast surgery....

FluidAI Medical Received FDA Clearance for Innovative Origin™ Post-Operative Monitoring Device

FluidAI Medical, a Canadian medical technology company specialising in artificial intelligence and sensor-based healthcare solutions, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Origin™ device — a key step in advancing data-driven post-operative care....

FDA Approves New Class of Wearable Biosensors for Continuous Patient Monitoring

The FDA has approved a new class of wearable biosensors designed for continuous patient monitoring in clinical settings....